Asymptomatic irreversible pulpitis. Asymptomatic irreversible pulpitis
Conditions
Interventions
Intervention 1: Intervention group: For the first group (18 to 40 years old), Intraosseous injection technique would be used to achieve primary pulpal anesthesia using a QuickSleeper 5 device produc
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: The age of the patient is over 18 years and under the age of 60 years Patient Satisfaction to enter the study Patients have the ability to read and understand the consent and sign it Patients should have at least one first vital mandibular molar without spontaneous pain and positive response to Electrical Pulp Tester and prolonged response to the cold test The absence of periapical radiolucency or any periapical lesions in radiography Patients without any systemic diseases Absence of acute inflammation and advanced periodontal disease at the first mandibular molar and adjacent Molar and premolar teeth and injection area
Exclusion criteria
Exclusion criteria: History of any cardiovascular disease and high blood pressure Lactate or pregnant women Any history of alergy to anesthetic solutions Using analgesic drugs since 12 hours before the treatment Mobility more than 0.5 mm Probing more than 3 mm in mesial and distal Severe dental pain that needs emergency treatment Non vital coronal pulp tissue Teeth with full crown No lip numbness after the Inferior Alveolar Nerve Block injection No pulp exposure after removing caries lack of cooperation or interest of patient to continue the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Success of the Anesthesia. Timepoint: After the Injection and during root canal therapy (RCT). Method of measurement: Vitality pulp test (Electrical pulp tester and endo ice) before RCT and questioning from patients during RCT.;Pain during injection. Timepoint: During injection of Anesthetic solution and immediately after completion of injection. Method of measurement: Heft-parker visual Analogue Scale.;Pain. Timepoint: Before injection (during vital pulp tests), after injection (during the evaluation of anesthesia success). Method of measurement: Heft-parker visual Analogue Scale.;Pulse. Timepoint: Before injection , after injection. Method of measurement: Pulse-oximeter.;Onset of Anesthesia. Timepoint: After the injection with 1-minute intervals for a period of 15 minutes. Method of measurement: Vitality pulp test (pulp tester and endo ice).;Duration of Anesthesia. Timepoint: From the beginning to the end of the treatment session. Method of measurement: Asking from the patients. | — |
Secondary
| Measure | Time frame |
|---|---|
| Anxiety. Timepoint: Before injection. Method of measurement: Visual Analogue Scale for Anxiety. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaeed Gharibian bejestani
Shahid Beheshti University of Medical Sciences
Outcome results
None listed